Head-to-head Comparison Between [18F]-FDG PET/CT and PET/MRI in Lymphomas
Recruiting
- Conditions
- PET/MRI
- Registration Number
- NCT05390632
- Lead Sponsor
- Peking University Cancer Hospital & Institute
- Brief Summary
Investigating the performance of 18F-FDG PET/CT and PET/MRI in lymphomas
- Detailed Description
In this study investigators evaluated Nodal and Extranodal Lymphoma Lesions uptake by 18F-FDG PET (PET/CT and PET/MR). Prior to treatment, all patients will undergo whole-body 18F-FDG PET/CT and PET/MR. The methods' efficiency was compared in the diagnosis of lymph node (LN) and organ involvement.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- pathologically diagnosed as lymphoma; Written informed consent for receiving PET/MRI after PET/CT examinations. cancer planned chemotherapy or immunotherapy scheme. expected survival ≥ 12 weeks
Exclusion Criteria
- cannot lie supine for half an hour; refuse to join the clinical researcher; severe liver or kidney dysfunction pregnancy or lactation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SUVmax 150 days Standardized uptake value of 18F-FDG PET/CT and PET/MRI for target lesion of subject or suspected tumor in each time point window (SUV)
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Peking University Cancer Hospital
🇨🇳Beijing, Card Holder's Billing State / Province, China